NoemaLife, Europe's leading provider of clinical and hospital software solutions, has launched HALIA, new middleware for clinical chemistry, microbiology and molecular biology labs. Utilising a rule-based engine to deliver all-round control over laboratory workflow and sample processing, HALIA's powerful functionality significantly improves laboratory efficiency, compliance and quality control.

The new HALIA middleware interface provides a complete web-based lab computerisation system, allowing central management and connection of all analysers through a single interface on any workstation.

HALIA's user-configurable rule-based engine enables autoverification, sample routing and real-time clinical data capture and management for greater quality control. By supporting open automation systems and addressing issues such as regulatory compliance, workforce reductions and enhanced quality control, HALIA effectively meets the challenges facing lab managers.

Responding to the increase in Point of Care Testing, HALIA offers a POCT Data Manager function. This gives lab managers a real-time overview of all the data relating to multiple blood gas analysers or other devices, including instrument maintenance schedules and QC alerts.

HALIA also provides detailed real-time data on total turnaround time (TAT) - a key performance indicator in large laboratories striving to increase throughput. Addressing the situation where works stops if a LIS/LIMS system goes down, HALIA's LIS/LIMS backup module allows manual input of sample information so that analysis can continue. Manual samples are then matched to LIS/LIMS data once the connection is restored.

Andrea Chiapponi, Managing Director of NoemaLife S.p.A., commented, ‘In addition to laboratories looking for open middleware which is vendor independent, HALIA will be of interest to IVD device vendors wanting to create turnkey solutions which include maximum LIS/LIMS connectivity. HALIA's vendor-independence also enables merging of laboratories and even hospitals with different LIS/LIMS solutions into a seamless wide area network. For example, HALIA can manage re-tests on different analysers deployed in separate labs and co-ordinate specimen storage information relating to multiple locations.'

HALIA takes middleware to new levels by providing complete flexibility with simplified integration for all healthcare situations.

For further information click here


About NoemaLife

NoemaLife is a leading provider of clinical and hospital IT Software Solutions, dedicated to the enhancement of workflow automation, cost savings and quality of care at every level of the healthcare delivery process. It has been listed on the Italian Stock Exchange (MTA) since 2006 (NOE-ISIN IT0004014533).

NoemaLife , which employs a staff of 700 qualified professionals worldwide, has a direct market presence in Italy, Germany, France, United Kingdom, Belgium, Argentina, Chile and the United Arab Emirates. It also operates in Latin America, Northern Europe and Australia through a distribution network. Thanks to its acquisition in 2011 of a majority stake in the French group Medasys, NoemaLife consolidated its role as leading European vendor of IT solutions for clinical processes.

The NoemaLife Group closed 2011 with consolidated sales of 48.5 million euros (+13% on 2010), EBITDA of 9.1 million (+20%) and a net profit for the year of 1.4 million euros.